Nga ra mắt thuốc điều trị COVID-19 đầu tiên được cấp phép

(Vietnam+) 07:55 12/06/2020

Ngày 11/6, Nga đã cho ra mắt loại thuốc điều trị bệnh viêm đường hô hấp cấp COVID-19 đầu tiên được cấp phép với tên gọi Avifavir, trong bối cảnh số ca mắc bệnh ở nước này đã vượt quá mốc 500.000 người.

4buQPuG7nuG7nEAyw5nhuqnhuqnEqOG7muG6peG6qnvhuqsyJOG7muG7knk8w5nhu5zhuq3DmeG7nDPhu7Dhuqvhu5zhuqs+YsOgQOG7nD17LGLhu5zhuqvhuq1d4buc4buXw73hu4bFqcahLeG7nsOa4bucPcOdYuG7nOG6q3s6NOG7nD3hurnhurNA4bucQFnhuqXhu5zhuqU+JeG6peG7kC8+4bue4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4bunJMOZI+G7muG7knk84bumZuG7nOG7nuG7ni9Tw5Lhu5x5PMOZ4bucPeG7qOG7nEA+NeG7nOG6rcOZ4bucM+G7sOG6q+G7nDI1xah74buc4bqrPmLDoEDhu5w9eyxi4buc4bqr4bqtXeG7nOG7uC40PuG7nOG7h3s6M+G7nD3hurnhurc0POG7nD7DoeG7nD5Z4bql4bucQFnhuqXhu5zhu5fDveG7hsWpxqEt4buew5rhu5w9w51i4buc4bqrezo04bucPeG6ueG6s0Dhu5xAWeG6peG7nOG6pT4l4bql4buc4buH4bqxe+G7nOG6qzo04bucPDh74buc4buL4buHeynDmeG7h3vhuq3DkuG7nOG6q+G6rTU0POG7nOG7uMOge+G7nEDGrzQ+4buc4bqpw6Dhu5xAw5nhu5wz4buwQOG7nOG7uC40PuG7nOG6teG7nDThurnhurFA4bucNOG7pmbhu5w94buo4buc4buH4bq54bqz4bqr4buc4bqnYuG7pOG7nDPDoEDhu5xS4bui4bui4buM4bui4bui4bui4bucNDzhurnhurd74buM4buQL+G6peG7kuG7kOG6peG7nEAyw5nhuqnhuqnEqOG7muG6peG7lTUjZuG7muG7kuG7kHszPOG7nEAyw5nhuqnhuqnEqOG7mkAz4bqpLeG6pT414bqrNeG7muG7nOG6q3vhuqsyJMSo4buaeTzDmeG7nOG6rcOZ4bucM+G7sOG6q+G7nOG6qz5iw6BA4bucPXssYuG7nOG6q+G6rV3hu5zhu5fDveG7hsWpxqEt4buew5rhu5w9w51i4buc4bqrezo04bucPeG6ueG6s0Dhu5xAWeG6peG7nOG6pT4l4bql4bucPls0PuG7nMavND7hu5zhu57hu5rhu5zhuqnhuq1AxKjhu5ovL0Dhu4wjPkA04buM4buHNC97MzwvIyThuqkx4bqrNeG6pS8jLeG7uMOZNeG6qz7DmTQ+PjXDmeG7jOG7hzQvNCThu4Phuqkv4bug4bui4bugUC/hu55UVCNS4buiVFJSUlHhuqtUUuG7oFQy4bue4buM4buDJOG7uOG6peG7muG7nMOZMuG6q8So4buaeTzDmeG7nOG6rcOZ4bucM+G7sOG6q+G7nOG6qz5iw6BA4bucPXssYuG7nOG6q+G6rV3hu5zhu5fDveG7hsWpxqEt4buew5rhu5w9w51i4buc4bqrezo04bucPeG6ueG6s0Dhu5xAWeG6peG7nOG6pT4l4bql4bua4bucI8OZ4bqrw5kt4bqlPjXhuqs1LTXhuq17PHs0w5kyLeG6qeG6rUDEqOG7mj7huqvhuqvhuqXhuqlPLy9AIzR7Mzzhu4zhu4d7JOG6qzTDmTPhuqUyYuG6qeG7jOG7hzQv4bqrU+G7oOG7oi9i4bqlMjXDmSMkIy/hu7g1MDUxw5kv4bug4bui4bug4buiX+G7olNf4bue4bueL8OZ4buHeynDmeG7h3vhuq3hu4ww4bqlPOG7muG7nC/hu5Lhu4vhu4d7KcOZ4buHe+G6reG7nD3hu6jhu5w94bq54bqzQOG7nEA+YmYhNOG7nD07NOG7nEDhu6RA4buc4bu4LjQ+4buc4buHey404buc4buH4bum4buc4bqlPjc0POG7nDE+4bukM+G7nOG6q8Woe+G7nHk8w5nhu4zhu5zDlWs0Pk/hu5zhu5UyNTUz4bu4JOG6rTzDlOG7kC/huqXhu5Lhu5DhuqXhu5xAMsOZ4bqp4bqpxKjhu5rhuqXhu5U1I2bhu5rhu5Lhuqrhuq01NDzhu5wz4bqj4bqr4buc4bqrPsOhNDzhu5xA4bukNeG7nOG7uOG7pDXhu5xAPn3DkuG7nOG6pmLDrOG7nOG7m8OdYuG7nOG6q+G6ueG7nOG6q+G6rcOqQOG7nOG6q3s74bql4buceTzDmeG7nMOV4bqsxqHFqcO5w5Thu5xAPjXhu5zhu7h7O+G6q+G7nDLDoeG7nOG6qz5iw6BA4buc4buL4buHeynDmeG7h3vhuq3hu5w9w51i4buc4bqrezo04bucPeG7qOG7nD3hurnhurNA4bucQGI0POG7nEBZ4bql4bucQD414bucQOG7pEDhu5zhu7guND7hu5zhu4d7LjThu5zhu4fhu6bhu5zhuqU+NzQ84bucMT7hu6Qz4buc4bqr4bqtOjThu5zhuqs14bumNOG7nOG6p2LDoEDhu4zhu5zhuqzGocWpw7nhu5wy4bum4bucPeG6rzThu5zhu4dd4bucQGI0POG7nEBZ4bql4bucMXs0PuG7nOG6pT594bucQD414bucPjXFqOG6q+G7nD3huqM0POG7nOG6qz7hur/hu5w0PD57LjPhu5zhuqs+YsOgQOG7nOG7h+G7puG7nEA24bucUuG7okvhu5xAw6Phu5zhuqU+w5004buc4bqr4bqtNTQ84buc4bqr4buy4bql4bucPTXhu6Y04buc4buXPiQz4bqsw5nhuq3hu5wt4bucND7hu6bhu5zhuqnGrzThu5zhu4ViWeG6q+G7nOG6qz5iw6BA4buc4buL4buHeynDmeG7h3vhuq3hu4zhu5Av4bql4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4buVNSNm4bua4buS4buV4bqj4bucRuG7nOG6qzvhu5x5PMOZ4bucPeG7qOG7nEBZ4bql4buc4bqlPiXhuqXhu5xAPjXhu5zhuqs+YsOgQOG7nOG7i+G7h3spw5nhu4d74bqt4buc4bqrPiQ14bucM+G6o+G6q+G7nOG6p2Lhu6Thu5zhuqvhuq1bND7hu5zhuqU+OuG7nEA+YuG7tDThu5w94buuQOG7nOG7uHsu4bqr4bucPeG6ueG6s0Dhu5zhuqs+w6pA4bucPnsuNOG7nOG6q+G6rTU0POG7nOG6qz7hurd74bucPHvDmTThu5w0POG7sDThu4zhu5zhu5fhu6RA4bucPjXFqOG6q+G7nD3huqM0POG7nOG6qz7hur/hu5w0PD57LjPhu5zhuqvFqHvhu5x5PMOZ4bucI3soNOG7nOG6rcOZ4bucND7DmTQ+4buc4buH4bum4bucQDbhu5zhuqdiZuG7nDPDoeG7nDQ+OeG7nD7huq804buc4bqpNeG7nOG7h+G6sXvhu5w0PnssYuG7nOG6p2LDoEDhu5w8e8OZ4bucMT7hu6RAw5Lhu5zhuqvhuq01NDzhu5zhu7jDoHvhu5xAxq80PuG7nCNdQD7hu5zhu7guND7hu5w9w5k0POG7nDJYZuG7nDLDmTThu5zhu4fhurF74buc4bqrw6BA4bucPeG6o+G7nDQ+w5k0PuG7jOG7kC/huqXhu5Lhu5DhuqXhu5xAMsOZ4bqp4bqpxKjhu5rhuqXhu5U1I2bhu5rhu5Lhu6fhuqF74buc4bqrYsOdNOG7nOG6q+G6reG6ueG6sUDDkuG7nDQ84bq54bq3e+G7nD3hurs0POG7nD3DnWLhu5zhuqzGocWpw7nhu5x2e+G6rXsyMuG7nMahM3vhuqvhuq17JOG7h+G7nEA+NeG7nOG7uHs74bqrw5Lhu5zhu5c+JDPhuqzDmeG6reG7nEA24bucMTvhu5w+NcWoQD7hu5zhuqnGrzThu5zhu4ViWeG6q+G7nD1l4buc4bqrPmLDoEDhu5w9IeG7nD17LGLhu5zhuqvhuq1d4bucQD414bucMT41xq80POG7nFPhu6Lhu4zhu6Lhu6Lhu6Lhu5w0POG6ueG6t3vhu5wzxIN74buc4bqrPuG7pDQ84buM4buc4bqqPiQ14bucw6E0POG7nMahM3vhuqvhuq17JOG7h8OS4bucQDbhu5w+4bqvNOG7nOG7nuG7ouG7nOG6p2LDoEDhu5w8e8OZ4bucPeG7qOG7nD0s4bucNDw+XeG7nDNiw5nhu5zhuqs+YsOgQOG7nOG7i+G7h3spw5nhu4d74bqt4bucQGXDmeG7nHk8w5nhu4zhu5Av4bql4buS4buQ4bql4bucQDLDmeG6qeG6qcSo4bua4bql4buVNSNm4bua4buS4buG4bqxe+G7nD7huq804bucUuG7ouG7ouG7jOG7ouG7ouG7ouG7nOG6q+G6reG6ueG6tzQ84bucPuG6s+G6pcOS4buceTzDmeG7nD3DmTQ84buc4buFO+G6peG7nOG6qz7hurvhu5xQ4buc4bqr4bqtOjThu5zhuqs+O+G7nDx74bqxe+G7nOG7hyzhu5zhuqnDoOG7nEDDmeG7nDPhu7BA4buc4bu4LjQ+4buc4buXw73hu4bFqcahLeG7nsOa4buM4buc4bqqYmbhu5w0Pns6NMOS4bucNOG6ueG6sUDhu5w04bumZuG7nDPhurF74bucQD4i4bucPD574bucND7hu7I04bucPuG6rzThu5xT4buMUuG7ouG7ouG7nEDDmeG7nOG6q+G6v+G7nOG7hzU0PMOS4bucM+G6o+G6q+G7nOG6q8Ot4bucMi7hu5zhuqvhurnhuq80POG7nD3DoHvhu5zhuqs+WeG6peG7nOG6qTXhu5zhu4fhurF74bucND57LGLhu5zhuqdiw6BA4bucPHvDmeG7nDE+4bukQOG7jOG7nOG7p3suNOG7nDQ+eyxi4bucPV3DmeG7nOG6pT7hurnhuq80PMOS4buc4bqr4bqtNTQ84bucPTbhu5xANuG7nOG6qz5l4bucPcOh4buceDXhuqkx4buHw5nDkuG7nD3hu6jhu5zhu7jhu7Dhuqvhu5w9w51i4bucI8Oi4buc4bu4OeG7nEDhu6RA4buc4bu4ey404buc4bqlPuG7pOG6peG7nOG6pT41NDzhu5zhuqs5w5nhu5w94bq54bqzQOG7nOG7pOG6peG7nD3hu67huqvhu5w9IeG7nDE+w6A0POG7nEA+O+G7nCNdQD7hu5zhu7guND7hu4wv4buM4buQL+G6peG7kuG7kOG6peG7nEAyw5nhuqnhuqnEqOG7muG6peG7i2Lhuqs+NeG6reG7muG7ksOV4buGeyThuqs0w5kzK8OU4buQL+G6peG7kg==